Research ArticleArticle
Safety of Etanercept and Methotrexate in Patients with Rheumatoid Arthritis and Hepatitis C Virus Infection: A Multicenter Randomized Clinical Trial
Florenzo Iannone, Giovanni La Montagna, Gianfilippo Bagnato, Elisa Gremese, AnnaRita Giardina and Giovanni Lapadula
The Journal of Rheumatology January 2014, jrheum.130658; DOI: https://doi.org/10.3899/jrheum.130658
Florenzo Iannone
From the Interdisciplinary Department of Medicine, Rheumatology Unit, Bari; Rheumatology Unit, II University of Naples, Naples; Rheumatology Unit, Messina; Università Cattolica del Sacro Cuore, Rome; Rheumatology Unit, University of Palermo, Italy. Florenzo Iannone has received consulting fees, speaking fees or honoraria (less than €10,000) from Pfizer, Merck, Abbott, Bristol-Myers Squibb, and UCB. F. Iannone, MD, PhD, Associate Professor of Rheumatology, Interdisciplinary Department of Medicine, Rheumatology Unit, Bari; G. La Montagna, MD, Rheumatology Unit, II University of Naples; G. Bagnato, MD, Rheumatology Unit, Messina; E. Gremese, MD, Università Cattolica del Sacro Cuore; A.R. Giardina, MD, Rheumatology Unit, University of Palermo; G. Lapadula, MD, Interdisciplinary Department of Medicine, Rheumatology Unit, Bari. Address correspondence to Dr. F. Iannone, Interdisciplinary Department of Medicine-Rheumatology Unit, Policlinico, Piazza G. Cesare 11, 70124 Bari, Italy. E-mail: florenzo.iannone@uniba.it. Accepted for publication October 1, 2013.
Giovanni La Montagna
From the Interdisciplinary Department of Medicine, Rheumatology Unit, Bari; Rheumatology Unit, II University of Naples, Naples; Rheumatology Unit, Messina; Università Cattolica del Sacro Cuore, Rome; Rheumatology Unit, University of Palermo, Italy. Florenzo Iannone has received consulting fees, speaking fees or honoraria (less than €10,000) from Pfizer, Merck, Abbott, Bristol-Myers Squibb, and UCB. F. Iannone, MD, PhD, Associate Professor of Rheumatology, Interdisciplinary Department of Medicine, Rheumatology Unit, Bari; G. La Montagna, MD, Rheumatology Unit, II University of Naples; G. Bagnato, MD, Rheumatology Unit, Messina; E. Gremese, MD, Università Cattolica del Sacro Cuore; A.R. Giardina, MD, Rheumatology Unit, University of Palermo; G. Lapadula, MD, Interdisciplinary Department of Medicine, Rheumatology Unit, Bari. Address correspondence to Dr. F. Iannone, Interdisciplinary Department of Medicine-Rheumatology Unit, Policlinico, Piazza G. Cesare 11, 70124 Bari, Italy. E-mail: florenzo.iannone@uniba.it. Accepted for publication October 1, 2013.
Gianfilippo Bagnato
From the Interdisciplinary Department of Medicine, Rheumatology Unit, Bari; Rheumatology Unit, II University of Naples, Naples; Rheumatology Unit, Messina; Università Cattolica del Sacro Cuore, Rome; Rheumatology Unit, University of Palermo, Italy. Florenzo Iannone has received consulting fees, speaking fees or honoraria (less than €10,000) from Pfizer, Merck, Abbott, Bristol-Myers Squibb, and UCB. F. Iannone, MD, PhD, Associate Professor of Rheumatology, Interdisciplinary Department of Medicine, Rheumatology Unit, Bari; G. La Montagna, MD, Rheumatology Unit, II University of Naples; G. Bagnato, MD, Rheumatology Unit, Messina; E. Gremese, MD, Università Cattolica del Sacro Cuore; A.R. Giardina, MD, Rheumatology Unit, University of Palermo; G. Lapadula, MD, Interdisciplinary Department of Medicine, Rheumatology Unit, Bari. Address correspondence to Dr. F. Iannone, Interdisciplinary Department of Medicine-Rheumatology Unit, Policlinico, Piazza G. Cesare 11, 70124 Bari, Italy. E-mail: florenzo.iannone@uniba.it. Accepted for publication October 1, 2013.
Elisa Gremese
From the Interdisciplinary Department of Medicine, Rheumatology Unit, Bari; Rheumatology Unit, II University of Naples, Naples; Rheumatology Unit, Messina; Università Cattolica del Sacro Cuore, Rome; Rheumatology Unit, University of Palermo, Italy. Florenzo Iannone has received consulting fees, speaking fees or honoraria (less than €10,000) from Pfizer, Merck, Abbott, Bristol-Myers Squibb, and UCB. F. Iannone, MD, PhD, Associate Professor of Rheumatology, Interdisciplinary Department of Medicine, Rheumatology Unit, Bari; G. La Montagna, MD, Rheumatology Unit, II University of Naples; G. Bagnato, MD, Rheumatology Unit, Messina; E. Gremese, MD, Università Cattolica del Sacro Cuore; A.R. Giardina, MD, Rheumatology Unit, University of Palermo; G. Lapadula, MD, Interdisciplinary Department of Medicine, Rheumatology Unit, Bari. Address correspondence to Dr. F. Iannone, Interdisciplinary Department of Medicine-Rheumatology Unit, Policlinico, Piazza G. Cesare 11, 70124 Bari, Italy. E-mail: florenzo.iannone@uniba.it. Accepted for publication October 1, 2013.
AnnaRita Giardina
From the Interdisciplinary Department of Medicine, Rheumatology Unit, Bari; Rheumatology Unit, II University of Naples, Naples; Rheumatology Unit, Messina; Università Cattolica del Sacro Cuore, Rome; Rheumatology Unit, University of Palermo, Italy. Florenzo Iannone has received consulting fees, speaking fees or honoraria (less than €10,000) from Pfizer, Merck, Abbott, Bristol-Myers Squibb, and UCB. F. Iannone, MD, PhD, Associate Professor of Rheumatology, Interdisciplinary Department of Medicine, Rheumatology Unit, Bari; G. La Montagna, MD, Rheumatology Unit, II University of Naples; G. Bagnato, MD, Rheumatology Unit, Messina; E. Gremese, MD, Università Cattolica del Sacro Cuore; A.R. Giardina, MD, Rheumatology Unit, University of Palermo; G. Lapadula, MD, Interdisciplinary Department of Medicine, Rheumatology Unit, Bari. Address correspondence to Dr. F. Iannone, Interdisciplinary Department of Medicine-Rheumatology Unit, Policlinico, Piazza G. Cesare 11, 70124 Bari, Italy. E-mail: florenzo.iannone@uniba.it. Accepted for publication October 1, 2013.
Giovanni Lapadula
From the Interdisciplinary Department of Medicine, Rheumatology Unit, Bari; Rheumatology Unit, II University of Naples, Naples; Rheumatology Unit, Messina; Università Cattolica del Sacro Cuore, Rome; Rheumatology Unit, University of Palermo, Italy. Florenzo Iannone has received consulting fees, speaking fees or honoraria (less than €10,000) from Pfizer, Merck, Abbott, Bristol-Myers Squibb, and UCB. F. Iannone, MD, PhD, Associate Professor of Rheumatology, Interdisciplinary Department of Medicine, Rheumatology Unit, Bari; G. La Montagna, MD, Rheumatology Unit, II University of Naples; G. Bagnato, MD, Rheumatology Unit, Messina; E. Gremese, MD, Università Cattolica del Sacro Cuore; A.R. Giardina, MD, Rheumatology Unit, University of Palermo; G. Lapadula, MD, Interdisciplinary Department of Medicine, Rheumatology Unit, Bari. Address correspondence to Dr. F. Iannone, Interdisciplinary Department of Medicine-Rheumatology Unit, Policlinico, Piazza G. Cesare 11, 70124 Bari, Italy. E-mail: florenzo.iannone@uniba.it. Accepted for publication October 1, 2013.
Article Information
jrheum.130658
PubMed
Published By
Print ISSN
Online ISSN
Article Versions
- You are currently viewing a Latest version of this article (January 15, 2014 - 12:30).
- View the most recent version of this article
Copyright & Usage
© 2014 The Journal of Rheumatology
Article usage
Statistics from Altmetric.com
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Safety of Etanercept and Methotrexate in Patients with Rheumatoid Arthritis and Hepatitis C Virus Infection: A Multicenter Randomized Clinical Trial
Florenzo Iannone, Giovanni La Montagna, Gianfilippo Bagnato, Elisa Gremese, AnnaRita Giardina, Giovanni Lapadula
The Journal of Rheumatology Jan 2014, jrheum.130658; DOI: 10.3899/jrheum.130658
Safety of Etanercept and Methotrexate in Patients with Rheumatoid Arthritis and Hepatitis C Virus Infection: A Multicenter Randomized Clinical Trial
Florenzo Iannone, Giovanni La Montagna, Gianfilippo Bagnato, Elisa Gremese, AnnaRita Giardina, Giovanni Lapadula
The Journal of Rheumatology Jan 2014, jrheum.130658; DOI: 10.3899/jrheum.130658